We are live on ! Find out more
VCYT icon

Veracyte

195 hedge funds and large institutions have $1.37B invested in Veracyte in 2019 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 71 increasing their positions, 50 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 14

42% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 50

39% more capital invested

Capital invested by funds: $983M → $1.37B (+$385M)

31% more funds holding

Funds holding: 149195 (+46)

4.45% more ownership

Funds ownership: 95.54%99.99% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

2% less call options, than puts

Call options by funds: $2.08M | Put options by funds: $2.12M

Holders
195
Holders Change
+46
Holders Change %
+30.87%
% of All Funds
4.24%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
63
Increased
71
Reduced
50
Closed
14
Calls
$2.08M
Puts
$2.12M
Net Calls
-$39K
Net Calls Change
+$1.11M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
26
Cannell Capital
Wyoming
$12.7M -$20.5M -821,319 -65%
AQR Capital Management
27
AQR Capital Management
Connecticut
$11.7M +$4.33M +173,504 +74%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$11.6M +$3.68M +147,500 +57%
CM
29
Castleark Management
Illinois
$11.6M +$4.19M +167,687 +70%
Northern Trust
30
Northern Trust
Illinois
$11.4M +$1.34M +53,792 +16%
Acadian Asset Management
31
Acadian Asset Management
Massachusetts
$11.2M +$951K +38,055 +11%
DCM
32
Driehaus Capital Management
Illinois
$10.6M +$6.29M +251,851 +207%
Wells Fargo
33
Wells Fargo
California
$10M +$4.61M +184,597 +111%
FCM
34
Farallon Capital Management
California
$9.98M +$8.74M +350,000 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$8.19M +$3.39M +135,902 +90%
LCM
36
Laurion Capital Management
New York
$7.91M -$1.93M -77,425 -22%
Point72 Asset Management
37
Point72 Asset Management
Connecticut
$7.5M -$378K -15,150 -5%
CCP
38
Clough Capital Partners
Massachusetts
$7.43M +$2.23M +89,400 +52%
Bank of America
39
Bank of America
North Carolina
$7.42M +$2.46M +98,666 +61%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$6.97M +$1.18M +47,367 +24%
CAM
41
Cortina Asset Management
Wisconsin
$6.9M -$1.46M -58,347 -19%
Two Sigma Investments
42
Two Sigma Investments
New York
$6.84M -$2.11M -84,290 -26%
EIM
43
Essex Investment Management
Massachusetts
$6.8M -$1.83M -73,389 -24%
Marshall Wace
44
Marshall Wace
United Kingdom
$6.72M +$3.96M +158,574 +206%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$6.36M +$4.94M +197,709 +785%
Charles Schwab
46
Charles Schwab
California
$6.32M +$1.39M +55,652 +34%
Alyeska Investment Group
47
Alyeska Investment Group
Illinois
$6.02M +$5.28M +211,182 New
FCMI
48
Foresite Capital Management IV
California
$5.7M +$5M +200,000 New
Calamos Advisors
49
Calamos Advisors
Illinois
$5.64M +$4.94M +197,919 New
SIM
50
Spark Investment Management
New York
$5.05M -$3.65M -146,100 -45%

VCYT Hedge Fund Activity: Q2 2019 in Review

195 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2019, worth a combined $1.37B — up 39% from $983M a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new VCYT positions and 14 closed out — a net gain of 49 holders — while 71 added to existing stakes and 50 trimmed.

The largest buyer was Invesco, adding an estimated $59.7M. The largest seller was Versant Venture Management, cutting an estimated $30.1M.

  • 195 institutional investors held Veracyte (VCYT) as of Q2 2019, up from 149 in Q1 2019.
  • Funds reported $1.37B of Veracyte stock for Q2 2019, up 39% quarter-over-quarter.
  • 63 funds opened new Veracyte positions in Q2 2019 and 14 closed out, a net change of +49 holders.
  • The largest Veracyte buyer in Q2 2019 was Invesco, an estimated $59.7M added.
  • The largest Veracyte seller in Q2 2019 was Versant Venture Management, an estimated $30.1M sold.

Based on aggregated 13F filings for Q2 2019.